Literature DB >> 15112968

Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia.

Steven M Zeitels1, Ramon A Franco, Seth H Dailey, James A Burns, Robert E Hillman, R Rox Anderson.   

Abstract

Treatment of glottal papillomatosis and dysplasia was mirror-guided and performed in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer anesthesia and procedural support. Presently, the primary treatment goals, which are disease regression and voice restoration or maintenance, are tempered by the morbidity of general anesthesia and potential treatment-induced vocal deterioration. In fact, general anesthesia has been appropriately considered to be an acceptable source of morbidity for the promise of a precise procedure, which usually ensures airway safety and an optimal vocal outcome. However, patients with recurrent glottal papillomatosis and keratosis with dysplasia are typically monitored with various degrees of watchful waiting until there is a subjective judgment (on the part of the patient and surgeon) that the disease is more of a liability than is the procedure to treat it. Innovations in the 585-nm pulsed dye laser delivery system have allowed for its use in the clinic with local anesthesia through the working channel of a flexible fiberoptic laryngoscope. A prospective assessment was done on 51 patients in 82 cases of recurrent glottal papillomatosis (30) and dysplasia (52). All individuals had previously undergone microlaryngoscopic management with histopathologic evaluation. Five procedures could not be completed because of impaired exposure (2) or discomfort (3). Of those patients who could be treated, there was at least a 50% disease involution in 68 of 77 cases (88%) and 25% to 50% disease regression in the remaining 9 (12%). Patient self-assessment of the voice revealed that 34 of 77 were improved, 39 were unchanged, 4 were slightly worse, and none were substantially worse. These data confirm that diseased mucosa can be normalized without resection or substantial loss of vocal function. The putative mechanisms, which vary according to the fluence (energy) delivered by the laser, are photoangiolysis of sublesional microcirculation. denaturing of epithelial basement membrane linking proteins, and cellular destruction. Furthermore, this relatively safe, effective technique allowed for treatment of many patients (in a clinic setting) in whom classic surgery-related morbidity would have often delayed intervention.

Entities:  

Mesh:

Year:  2004        PMID: 15112968     DOI: 10.1177/000348940411300403

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  12 in total

1.  Photocoagulation therapy for laryngeal dysplasia using angiolytic lasers.

Authors:  Yo Kishimoto; Ryo Suzuki; Yoshitaka Kawai; Nao Hiwatashi; Morimasa Kitamura; Ichiro Tateya; Shigeru Hirano
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

2.  595 nm pulsed dye laser for the treatment of superficial basal cell carcinoma.

Authors:  P Campolmi; L Mavilia; P Bonan; G Cannarozzo; T M Lotti
Journal:  Lasers Med Sci       Date:  2005-11-18       Impact factor: 3.161

3.  Office-based Management of Recurrent Respiratory Papilloma.

Authors:  Kevin M Motz; Alexander T Hillel
Journal:  Curr Otorhinolaryngol Rep       Date:  2016-03-31

4.  Longstanding recurrent laryngeal papillomatosis: impact on voice quality.

Authors:  Laura Lehto; Leena-Maija Aaltonen; Heikki Rihkanen
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-24       Impact factor: 2.503

Review 5.  [Laryngeal papillomatosis: etiology, diagnostics and therapy].

Authors:  M Andratschke; C Betz; A Leunig
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

6.  Office-based procedures in laryngology.

Authors:  Marta Filauro; Alberto Vallin; Marco Fragale; Claudio Sampieri; Luca Guastini; Francesco Mora; Giorgio Peretti
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-12-29       Impact factor: 2.124

Review 7.  Current and future management of recurrent respiratory papillomatosis.

Authors:  Ryan Ivancic; Hassan Iqbal; Brad deSilva; Quintin Pan; Laura Matrka
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-01-14

8.  Treatment of Hemorrhagic Vocal Polyps by Pulsed Dye Laser-Assisted Laryngomicrosurgery.

Authors:  Hyung Kwon Byeon; Ji Hyuk Han; Byeong Il Choi; Hye Jin Hwang; Ji-Hoon Kim; Hong-Shik Choi
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

9.  Transnasal Flexible Fiberoptic in-office Laryngeal Biopsies-Our Experience with 117 Patients with Suspicious Lesions.

Authors:  Jacob T Cohen; Limor Benyamini
Journal:  Rambam Maimonides Med J       Date:  2014-04-28

10.  Office-based CO2 laser surgery for benign and premalignant laryngeal lesions.

Authors:  David J Wellenstein; Jimmie Honings; Anouk S Schimberg; Henrieke W Schutte; Jasmijn M Herruer; Frank J A van den Hoogen; Robert P Takes; Guido B van den Broek
Journal:  Laryngoscope       Date:  2019-09-09       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.